Intravenous immunoglobulin treatment of spleen cells from patients with immune thrombocytopenia significantly increases the percentage of myeloid-derived suppressor cells-Reference-Cited by-同舟云学术

Intravenous immunoglobulin treatment of spleen cells from patients with immune thrombocytopenia significantly increases the percentage of myeloid-derived suppressor cells

Published:2017-02-06 Issue:2 Volume:181 Page:262-264
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Aslam Rukhsana¹,Burack W. Richard²,Segel George B.²,McVey Mark¹³⁴⁵,Spence Stephen A.²,Semple John W.¹³⁶⁷⁸

Affiliation:

1. Keenan Research Centre for Biomedical Science of St. Michaels Hospital; Rochester NY USA

2. Departments of Medicine and Pathology; University of Rochester School of Medicine; Rochester NY USA

3. Canadian Blood Services; Toronto ON Canada

4. Departments of Physiology and Anesthesia; University of Toronto; Toronto ON Canada

5. Department of Anesthesia and Pain Medicine; Hospital for Sick Children; Toronto ON Canada

6. Department of Pharmacology; University of Toronto; Toronto ON Canada

7. Department of Medicine; University of Toronto; Toronto ON Canada

8. Department of Laboratory Medicine and Pathobiology; University of Toronto; Toronto ON Canada. Division of Haematology and Transfusion Medicine; Lund University; Lund Sweden

Funder

Health Canada

National Center for Advancing Translational Sciences

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14542/fullpdf

Reference8 articles.

1. Splenic lymphocytes in immune thrombocytopenia (ITP): increased presence of a subtype of B-regulatory cells;Aslam;British Journal of Haematology,2016

2. MDSC in autoimmunity;Cripps;International Immunopharmacology,2011